Skip to content

Research on Innovative Technologies for Early Diagnosis and Screening of Cancer

Research on Innovative Technologies for Early Diagnosis and Screening of Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109299
Enrollment
Unknown
Registered
2025-09-16
Start date
2024-06-04
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, gastric cancer, colorectal cancer, breast cancer, thyroid cancer, etc.

Interventions

Tumor Experimental Group
Healthy control group:NA

Sponsors

Xi'an Fengcheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Experimental group:; 1. Have been diagnosed with a specific type of cancer(Lung cancer,liver cancer, gastric cancer, etc.); 2. Have not received any treatment or surgery,including interventions such as chemotherapy,radiotherapy, surgery, etc.; 3. Be aged 18 or above . Control group:; 1. Healthy individuals confirmed to have no history of cancer or other major diseases through physical examination and other methods.; 2. The age and gender of the tumor patients were matched to ensure the scientific nature of the comparative analysis; 3. Be aged 18 or above and meet other conditions of the study.

Exclusion criteria

Exclusion criteria: Experimental group:; 1. Patients who have received any form of anti-tumor treatment or surgery; 2. Patients who suffer from other serious concurrent diseases (such as severe cardiovascular diseases, infectious diseases, etc.) that may affect the research results. results. 3. There are other situations where complete samples cannot be obtained or where the detection results are interfered with; 4. Age less than 18 years old. Control group:; 1. Have a history of cancer or other major illnesses; 2. Is currently receiving medication or has an unstable health condition, such as an acute episode of a chronic disease; 3. There are other situations where complete samples cannot be obtained or where the detection results are interfered with; 4. Age less than 18 years old.

Design outcomes

Primary

MeasureTime frame
Tryptophan;Lysine;Cysteine;Tyrosine;

Countries

China

Contacts

Public ContactCong Tang

Xi'an Fengcheng Hospital

tangc1025@gmail.com+86 29 86530930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026